The concept of metabolic syndrome has emerged across disciplines in the biomedical and health sciences as a loosely defined set of statistical risk factors that purport to predict heart disease, diabetes, and other poor health outcomes (Hatch 2016). While there remains little consensus over how to define metabolic syndrome, to what extent the syndrome is a predictive factor of heart and digestive-related diseases, and what factors cause metabolic syndrome, there have been recent attempts to create standardized definitions. Most recently, the National Cholesterol Education Program (NCEP) defined metabolic syndrome using measurements of blood pressure, fasting blood sugar, LDL and HDL cholesterol, and abdominal circumference. Anthony Ryan Hatch's Blood Sugar: Racial Pharmacology and Food Justice in Black America explores the consequences of creating standardized definitions of metabolic syndrome by questioning how research on this syndrome shapes knowledge of racial health disparities, and to what extent it benefits people on ground level...
Blood Sugar: Racial Pharmacology and Food Justice in Black America
Peter Kent-Stoll is an M.A. candidate at the Center for Medicine, Health, and Society at Vanderbilt University. Before coming to Vanderbilt, he received his B.A. in public health policy from the University of California, Irvine. He has research interests in science & technology studies, social movements, gender & sexuality, and race & ethnicity. He studies the ways in which discourses of cancer advocacy and other forms of disease activism in the United States are impacted by and impact racial and gender inequality.
Peter Kent-Stoll; Blood Sugar: Racial Pharmacology and Food Justice in Black America. J Health Polit Policy Law 1 April 2017; 42 (2): 413–417. doi: https://doi.org/10.1215/03616878-3766799
Download citation file: